Odilson M Silvestre1, Alexandra Gonçalves1,2, Wilson Nadruz1,3, Brian Claggett1, David Couper4, John H Eckfeldt5, James S Pankow5, Stefan D Anker6, Scott D Solomon1. 1. Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. 2. University of Porto Medical School, Porto, Portugal. 3. University of Campinas, Campinas, Brazil. 4. University of North Carolina, NC, USA. 5. University of Minnesota, Minneapolis, MN, USA. 6. Innovative Clinical Trials, Department of Cardiology & Pneumology, University Medical Centre Göttingen (UMG), Göttingen, Germany.
Abstract
AIMS: Severe iron overload is associated with cardiac damage, while iron deficiency has been related to worse outcomes in subjects with heart failure (HF). This study investigated the relationship between ferritin, a marker of iron status, and the incidence of HF in a community-based cohort. METHODS AND RESULTS: We examined 1063 participants who were free of heart failure from the Atherosclerosis Risk in Communities (ARIC) Study in whom ferritin serum levels were measured at baseline (1987-1989). The participants (mean age 52.7 ± 5.5 years, 62% women), were categorized in low (<30 ng/mL; n = 153), normal (30-200 ng/mL in women and 30-300 ng/mL in men; n = 663), and high (>200 ng/mL in women and >300 ng/mL in men; n = 247) ferritin levels. Multivariable Cox proportional hazards models were used to evaluate the relationship between ferritin and incident HF. After 21 ± 4.6 years of follow-up, HF occurred in 144 (13.5%) participants. When compared with participants with normal ferritin levels, participants with low ferritin levels had a higher risk of HF [hazard ratio (HR) = 2.24, 95% confidence interval (CI) 1.15-4.35; P = 0.02] as did those with high ferritin levels (HR = 1.81, 95% CI 1.01-3.25; P = 0.04), after adjusting for potential confounders. Notably, low ferritin levels remained associated with incident HF even after excluding subjects with anaemia (HR = 2.28, 95% CI 1.11-4.68; P = 0.03). CONCLUSION: Derangements in iron metabolism, either low or high ferritin serum levels, were associated with higher risk of incident HF in a general population, even without concurrent anaemia. These findings suggest that iron imbalance might play a role in the development of HF.
AIMS: Severe iron overload is associated with cardiac damage, while iron deficiency has been related to worse outcomes in subjects with heart failure (HF). This study investigated the relationship between ferritin, a marker of iron status, and the incidence of HF in a community-based cohort. METHODS AND RESULTS: We examined 1063 participants who were free of heart failure from the Atherosclerosis Risk in Communities (ARIC) Study in whom ferritin serum levels were measured at baseline (1987-1989). The participants (mean age 52.7 ± 5.5 years, 62% women), were categorized in low (<30 ng/mL; n = 153), normal (30-200 ng/mL in women and 30-300 ng/mL in men; n = 663), and high (>200 ng/mL in women and >300 ng/mL in men; n = 247) ferritin levels. Multivariable Cox proportional hazards models were used to evaluate the relationship between ferritin and incident HF. After 21 ± 4.6 years of follow-up, HF occurred in 144 (13.5%) participants. When compared with participants with normal ferritin levels, participants with low ferritin levels had a higher risk of HF [hazard ratio (HR) = 2.24, 95% confidence interval (CI) 1.15-4.35; P = 0.02] as did those with high ferritin levels (HR = 1.81, 95% CI 1.01-3.25; P = 0.04), after adjusting for potential confounders. Notably, low ferritin levels remained associated with incident HF even after excluding subjects with anaemia (HR = 2.28, 95% CI 1.11-4.68; P = 0.03). CONCLUSION: Derangements in iron metabolism, either low or high ferritin serum levels, were associated with higher risk of incident HF in a general population, even without concurrent anaemia. These findings suggest that iron imbalance might play a role in the development of HF.
Authors: John N Nanas; Charis Matsouka; Drosos Karageorgopoulos; Anastasia Leonti; Elias Tsolakis; Stavros G Drakos; Eleftheria P Tsagalou; George D Maroulidis; George P Alexopoulos; John E Kanakakis; Maria I Anastasiou-Nana Journal: J Am Coll Cardiol Date: 2006-11-28 Impact factor: 24.094
Authors: M C Corti; J M Guralnik; M E Salive; L Ferrucci; M Pahor; R B Wallace; C H Hennekens Journal: Am J Cardiol Date: 1997-01-15 Impact factor: 2.778
Authors: Darlington O Okonko; Amit K J Mandal; Constantinos G Missouris; Philip A Poole-Wilson Journal: J Am Coll Cardiol Date: 2011-09-13 Impact factor: 24.094
Authors: Ijsbrand T Klip; Douwe Postmus; Adriaan A Voors; Frank P J Brouwers; Ron T Gansevoort; Stephan J L Bakker; Hans L Hillege; Rudolf A de Boer; Pim van der Harst; Wiek H van Gilst; Dirk J van Veldhuisen; Peter van der Meer Journal: Am Heart J Date: 2014-09-28 Impact factor: 4.749
Authors: Noemí Corante; Cecilia Anza-Ramírez; Rómulo Figueroa-Mujíca; José Luis Macarlupú; Gustavo Vizcardo-Galindo; Grzegorz Bilo; Gianfranco Parati; Jorge L Gamboa; Fabiola León-Velarde; Francisco C Villafuerte Journal: High Alt Med Biol Date: 2018-05-21 Impact factor: 1.981
Authors: Ridha I S Alnuwaysir; Martijn F Hoes; Dirk J van Veldhuisen; Peter van der Meer; Niels Grote Beverborg Journal: J Clin Med Date: 2021-12-27 Impact factor: 4.964